化疗引起的腹与肠道微生物组组成之间的关系
Yuka Kawasaki1, Kazuki Kakimoto1, Yasuyoshi Tanaka1
12nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Digestion
|May 26, 2023
概括
结直肠癌患者的化疗引起的腹与肠道细菌的显著变化有关,特别是有益的Bifidobacterium的减少. 了解这种肠道微生物组的转变可以帮助管理副作用.
科学领域:
- 在瘤学瘤学.
- 微生物组研究 微生物组研究
- 胃肠病学 胃肠病学
背景情况:
- 甲胺 (FPs) 是重要的化疗剂,但由于胃肠道毒性,通常会引起腹.
- 肥胖症破坏肠道屏障,导致细胞损伤和腹的恶化.
- 化疗诱导的抗生素失调和腹之间的确切联系尚不清楚.
研究的目的:
- 为了研究化疗引起的腹和肠道微生物群之间的关系.
- 分析基于皮里米丁的化疗后肠道微生物组成的变化.
主要方法:
- 一项前性观察性研究包括23名接受一线胺化疗的结直肠癌患者.
- 化疗前和循环后收集便样本进行微生物组分析.
- 进行了PICRUSt预测元基因组分析,以推断功能变化.
主要成果:
- 腹发生在17.4%的患者中.
- 化疗显著降低了患有腹的患者的肠道微生物α多样性.
- 腹患者的Firmicutes数量减少,Bacteroidetes数量增加,同时Bifidobacterium数量减少.
结论:
- 化疗引起的腹与肠道微生物组的特定变化有关.
- 有机酸产生细菌的减少,如Bifidobacterium,可能在化疗相关的腹中起作用.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
167
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
167
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
261
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
261
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
256
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
256
Anatomy of the Intestines
72.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.7K
Drugs for Treatment of Diarrhea-Predominant IBS
224
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
224
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
369
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
369


